0001628280-23-023956.txt : 20230629
0001628280-23-023956.hdr.sgml : 20230629
20230629192229
ACCESSION NUMBER: 0001628280-23-023956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230627
FILED AS OF DATE: 20230629
DATE AS OF CHANGE: 20230629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Laura A
CENTRAL INDEX KEY: 0001869194
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 231058919
MAIL ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
wk-form4_1688080938.xml
FORM 4
X0407
4
2023-06-27
0
0001437402
ARDELYX, INC.
ARDX
0001869194
Williams Laura A
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-06-27
4
S
0
25000
3.3453
D
294430
D
This transaction was executed in multiple trades in prices ranging from $3.331 to $3.365, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Elizabeth Grammer, Attorney-in-Fact for Laura A. Williams
2023-06-29